These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 17224239)

  • 1. The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.
    Konieczny J; Wardas J; Kuter K; Pilc A; Ossowska K
    Neuroscience; 2007 Mar; 145(2):611-20. PubMed ID: 17224239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats.
    Ossowska K; Konieczny J; Wardas J; Pietraszek M; Kuter K; Wolfarth S; Pilc A
    Amino Acids; 2007 Feb; 32(2):179-88. PubMed ID: 16699817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiparkinsonian action of a selective group III mGlu receptor agonist is associated with reversal of subthalamonigral overactivity.
    Lopez S; Jouve L; Turle-Lorenzo N; Kerkerian-Legoff L; Salin P; Amalric M
    Neurobiol Dis; 2012 Apr; 46(1):69-77. PubMed ID: 22245662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of striatal metabotropic glutamate receptors in Parkinson's disease.
    Ossowska K; Konieczny J; Wardas J; Gołembiowska K; Wolfarth S; Pilc A
    Amino Acids; 2002; 23(1-3):193-8. PubMed ID: 12373537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
    Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M
    Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of metabotropic glutamate receptors in regulation of striatal proenkephalin expression: implications for the therapy of Parkinson's disease.
    Wardas J; Pietraszek M; Wolfarth S; Ossowska K
    Neuroscience; 2003; 122(3):747-56. PubMed ID: 14622918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiolytic- and antidepressant-like effects of group III metabotropic glutamate agonist (1S,3R,4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid (ACPT-I) in rats.
    Tatarczyńska E; Pałucha A; Szewczyk B; Chojnacka-Wójcik E; Wierońska J; Pilc A
    Pol J Pharmacol; 2002; 54(6):707-10. PubMed ID: 12866729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of striatal synaptotagmin mRNA isoforms in hemiparkinsonian rats.
    Glavan G; Zivin M
    Neuroscience; 2005; 135(2):545-54. PubMed ID: 16111820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.
    Stachowicz K; Kłodzińska A; Palucha-Poniewiera A; Schann S; Neuville P; Pilc A
    Neuropharmacology; 2009 Sep; 57(3):227-34. PubMed ID: 19539634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration.
    Holmer HK; Keyghobadi M; Moore C; Menashe RA; Meshul CK
    Synapse; 2005 Aug; 57(2):100-12. PubMed ID: 15906381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA.
    Cenci MA; Lee CS; Björklund A
    Eur J Neurosci; 1998 Aug; 10(8):2694-706. PubMed ID: 9767399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting group III metabotropic glutamate receptors produces complex behavioral effects in rodent models of Parkinson's disease.
    Lopez S; Turle-Lorenzo N; Acher F; De Leonibus E; Mele A; Amalric M
    J Neurosci; 2007 Jun; 27(25):6701-11. PubMed ID: 17581957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance between striatal expression of Fos, proenkephalin mRNA, prodynorphin mRNA and rotation induced by l-stepholidine in 6-hydroxydopamine-lesioned rats.
    Ding YM; Tang FM; Yu LP; Fu Y; Zhang GY; Jin GZ
    Acta Pharmacol Sin; 2000 Oct; 21(10):885-92. PubMed ID: 11501038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ; Marshall JF
    Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The striopallidal pathway is involved in antiparkinsonian-like effects of the blockade of group I metabotropic glutamate receptors in rats.
    Ossowska K; Wardas J; Pietraszek M; Konieczny J; Wolfarth S
    Neurosci Lett; 2003 May; 342(1-2):21-4. PubMed ID: 12727308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of the mGluR7 receptor to antiparkinsonian-like effects in rats: a behavioral study with the selective agonist AMN082.
    Konieczny J; Lenda T
    Pharmacol Rep; 2013; 65(5):1194-203. PubMed ID: 24399715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of transmitter release by high-affinity group III mGluRs in the supraoptic nucleus of the rat hypothalamus.
    Panatier A; Poulain DA; Oliet SH
    Neuropharmacology; 2004 Sep; 47(3):333-41. PubMed ID: 15275822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional interaction between adenosine A2A and group III metabotropic glutamate receptors to reduce parkinsonian symptoms in rats.
    Lopez S; Turle-Lorenzo N; Johnston TH; Brotchie JM; Schann S; Neuville P; Amalric M
    Neuropharmacology; 2008 Sep; 55(4):483-90. PubMed ID: 18625257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zonisamide enhances delta receptor-associated neurotransmitter release in striato-pallidal pathway.
    Yamamura S; Ohoyama K; Nagase H; Okada M
    Neuropharmacology; 2009 Sep; 57(3):322-31. PubMed ID: 19482038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
    Campbell BM; Kreipke CW; Walker PD
    Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.